clinical trials

Revumenib: Hopeful drug to fight leukemia

Published on: March 17, 2023
17:15

By: Pavel López Lazo

Washington, Mar 17 (Prensa Latina) Syndax Pharmaceuticals, Inc. on Friday announced it found data from the Phase 1 portion of the ongoing Phase 1/2 AUGMENT-101 trial of revumenib in patients with nucleophosmin mutant (mNPM1) and KMT2A-rearranged (KMT2Ar) relapsed/refractory (R/R) acute leukemia.

Research on patients for drug trials to continue in Cuba

Published on: July 14, 2022
09:06

By: Aleynes Palacios Hurtado

Havana, Jul 14 (Prensa Latina) The classification consultations for patients with Alzheimer's disease who will soon be part of the phase III clinical trial of the Cuban neuroprotective drug NeuralCIM (NeuroEPO) will continue in this city on Thursday

Cuban scientists endorse safety of Soberana 02 vaccine for children

Covid-19
Published on: January 26, 2022
12:53

By: Juan M. Garcia

Havana, Jan 26 (Prensa Latina) The safety of Cuba's homegrown Soberana 02 Covid-19 vaccine for use in children was endorsed on Wednesday at the Scientific Results Workshop on the clinical trials carried out in that population segment.

NEWS

clinical trials

Revumenib: Hopeful drug to fight leukemia

Research on patients for drug trials to continue in Cuba

Cuban scientists endorse safety of Soberana 02 vaccine for children

LATEST NEWS